[PDF] Top 20 Formulation and Evaluation of Mucoadhesive Buccal Tablet of Repaglinide
Has 10000 "Formulation and Evaluation of Mucoadhesive Buccal Tablet of Repaglinide" found on our website. Below are the top 20 most common "Formulation and Evaluation of Mucoadhesive Buccal Tablet of Repaglinide".
Formulation and Evaluation of Mucoadhesive Buccal Tablet of Repaglinide
... The drug release profile was studied using USP dissolution testing apparatus method II using a paddle at 50 rpm 900ml dissolution fluid, pH 6.8 phosphate buffer, was used and a temperature of 37 ±0.5°C was maintained. ... See full document
10
FORMULATION AND EVALUATION OF MUCOADHESIVE BUCCAL TABLETS OF CANDESARTAN
... The Mucoadhesive buccal tablets were prepared by direct compression method using carbopol 934, HPMC K4M, sodium CMC as mucoadhesive ...swelling, mucoadhesive strength and drug release. ... See full document
8
FORMULATION AND INVITRO EVALUATION OF MUCOADHESIVE FLOATING MICROSPHERES OF REPAGLINIDE
... The purpose of this study is to formulation and invitro evaluation of gastro retentive floating microspheres of Repaglinide using solvent evaporation method. The floating microspheres were taken for ... See full document
13
FORMULATION AND EVALUATION OF MUCOADHESIVE BUCCAL TABLETS OF PROPRANOLOL PREPARED USING NATURAL POLYMER
... The mucoadhesive buccal tablets of propranolol were papered by wet granulation method using natural polymer like Vigna mungo ...swelling, mucoadhesive strength, residence time and drug release. ... See full document
9
Formulation and evaluation of mucoadhesive buccal tablets of Furosemide
... effective mucoadhesive buccal tablets of Furosemide were prepared by direct compression method using bioadhesive polymers like Xanthan gum, Tamarind gum and synthetic polymers like HPMC K15M, HPMC K100M and ... See full document
6
FORMULATION AND IN VITRO EVALUATION OF MUCOADHESIVE BUCCAL TABLET OF LOSARTAN POTASSIUM USING SYNTHETIC AND NATURAL POLYMERS
... Losartan potassium is an angiotensin II receptor (type AT1) antagonist. The Losartan is an orally active agent that undergoes substantial first-pass metabolism by cytochrome P450 enzymes. The Losartan is freely soluble ... See full document
14
Formulation and evaluation of mucoadhesive buccal tablets of solifenacin
... designed formulation may result in substantial dose reduction of the dosage form when the drug is administered through oral mucosa so that it will be economical to the ... See full document
12
FORMULATION AND EVALUATION OF VENLAFAXINE HYDROCHLORIDE MUCOADHESIVE BUCCAL TABLETS
... first buccal tablet (n=3) was stacked to the glass slide with the help of knob, which was situated at the base of physical ...the tablet over the membrane with a weight of ...the tablet just ... See full document
6
Formulation and evaluation of mucoadhesive buccal tablets of nifedipine by using natural mucoadhesive polymers
... the mucoadhesive and the mucous membrane, with spreading and swelling of the formulation, initiating its deep contact with the mucus ...direct formulation attachment over the mucous membrane is not ... See full document
6
FORMULATION AND EVALUATION OF MUCOADHESIVE BUCCAL TABLETS BY USING NATURAL POLYMER
... the buccal tablets was determined in order to investigate the possibility of any side effects in- ...the buccal mucosa, it was determined to keep the surface pH as close to neutral as ...the tablet. ... See full document
10
Formulation and evaluation of mucoadhesive buccal tablets of montelukast sodium
... Oral delivery involves the administration of the desired drug through the Oral mucosal membrane lining of the oral cavity. Unlike oral drug delivery, which presents a hostile environment for drugs, especially proteins ... See full document
6
FORMULATION AND EVALUATION OF MUCOADHESIVE BUCCAL TABLET OF GLICLAZIDE USING 23 FULL FACTORIAL DESIGN
... The buccal route is considered as the most preferred route in case of bioadhesive drug delivery ...the buccal mucosa has gained significant attention due to its convenient ...The buccal mucosa offers ... See full document
12
FORMULATION AND EVALUATION OF MUCOADHESIVE BUCCAL TABLETS OF NITRENDIPINE
... > buccal route > palatal. The buccal region of the oral cavity is an attractive target for administration of the drug of choice, particularly in overcoming deficiencies associated with the latter mode ... See full document
17
Formulation and Evaluation of Nebivolol Mucoadhesive Buccal Tablet
... high mucoadhesive strength of this formulation is likely to increase its residence time in the gastrointestinal tract, which eventually improves the extent of ...formulating mucoadhesive tablets of ... See full document
17
DEVELOPMENT AND IN-VITRO EVALUATION OF CARVEDILOL LOADED MUCOADHESIVE BUCCAL TABLET
... Buccal delivery is considered to be an important alternative to theper oral route for the systemic administration of ...evaluate mucoadhesive buccal tablets of Carvedilol for systemic ...Carvedilol ... See full document
5
FORMULATION AND EVALUATION OF MUCOADHESIVE BILAYER BUCCAL TABLETS OF SALBUTAMOL SULPHATE
... and evaluation of mucoadhesive bilayer buccal tablets salbutamol ...develop mucoadhesive buccal tablets of salbutamol sulphate that could be applied to the buccal mucosa to ... See full document
21
Formulation and Evaluation of Mucoadhesive Buccal Patches of Dimenhydrinate.
... The buccal region of the oral cavity is an attractive target for administration of the drug of ...released buccal patch over period of 6 ...preparing mucoadhesive buccal ...The ... See full document
157
FORMULATION AND EVALUATION OF BUCCAL TABLET OF SALBUTAMOL SULPHATE
... all formulation batches were found to be in the range of ...the buccal tablet on freshly cut sheep buccal ...the formulation batches containing carbopol (F8, F9, F10) followed by ... See full document
5
FORMULATION AND EVALUATION OF PANTOPRAZOLE MUCOADHESIVE BUCCAL FILMS
... Mucoadhesive buccal films are preferably formulated using the solvent casting method, whereby the water soluble ingredients are dissolved to form a clear viscous solution and the drug along with other ... See full document
9
Formulation and Evaluation of Mucoadhesive Buccal Patches of Resperidone
... for buccal controlled delivery due to their ability to localize the dosage form in specific regions to enhance drug ...through buccal mucosa overcomes premature drug degradation within GI tract, as well as ... See full document
7
Related subjects